Elanco Animal Health (NASDAQ:ELAN) has received an average recommendation of “Hold” from the fourteen ratings firms that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $33.22.
ELAN has been the topic of several analyst reports. William Blair initiated coverage on shares of Elanco Animal Health in a report on Monday, February 11th. They issued a “market perform” rating and a $29.71 target price on the stock. UBS Group initiated coverage on shares of Elanco Animal Health in a report on Wednesday, January 23rd. They issued a “sell” rating and a $29.00 target price on the stock. Argus initiated coverage on shares of Elanco Animal Health in a report on Tuesday, January 15th. They issued a “buy” rating and a $37.00 target price on the stock. Credit Suisse Group reaffirmed a “hold” rating and issued a $33.00 target price on shares of Elanco Animal Health in a report on Friday, January 4th. Finally, Morgan Stanley initiated coverage on shares of Elanco Animal Health in a report on Wednesday, March 13th. They issued an “equal weight” rating and a $34.00 target price on the stock.
In related news, Director R David Hoover acquired 20,000 shares of Elanco Animal Health stock in a transaction that occurred on Wednesday, March 13th. The stock was purchased at an average price of $31.43 per share, for a total transaction of $628,600.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Elanco Animal Health stock traded down $0.43 during midday trading on Monday, hitting $32.14. 2,943,400 shares of the company’s stock were exchanged, compared to its average volume of 8,984,943. Elanco Animal Health has a 12-month low of $28.00 and a 12-month high of $37.61.
Elanco Animal Health (NASDAQ:ELAN) last issued its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The business had revenue of $799.30 million for the quarter, compared to analysts’ expectations of $804.07 million. During the same period in the previous year, the business posted $0.12 earnings per share. The company’s revenue for the quarter was up 6.0% on a year-over-year basis.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Featured Article: What is a Derivative?
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.